Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Abvc Biopharma (ABVC) Non Operating Investment Income (2018 - 2020)

Abvc Biopharma (ABVC) has disclosed Non Operating Investment Income for 3 consecutive years, with $665.0 as the latest value for Q3 2020.

  • For the quarter ending Q3 2020, Non Operating Investment Income rose 101.03% year-over-year to $665.0, compared with a TTM value of -$130934.0 through Sep 2020, changed N/A, and an annual FY2025 reading of -$192759.0, up 43.17% over the prior year.
  • Non Operating Investment Income was $665.0 for Q3 2020 at Abvc Biopharma, up from -$38937.0 in the prior quarter.
  • Across five years, Non Operating Investment Income topped out at $288062.0 in Q4 2018 and bottomed at -$85923.0 in Q2 2018.
  • Average Non Operating Investment Income over 3 years is $11867.5, with a median of -$33455.0 recorded in 2019.
  • The sharpest move saw Non Operating Investment Income tumbled 109.71% in 2019, then surged 101.03% in 2020.
  • Year by year, Non Operating Investment Income stood at $288062.0 in 2018, then crashed by 109.71% to -$27973.0 in 2019, then skyrocketed by 102.38% to $665.0 in 2020.
  • Business Quant data shows Non Operating Investment Income for ABVC at $665.0 in Q3 2020, -$38937.0 in Q2 2020, and -$27973.0 in Q4 2019.